2015
DOI: 10.9778/cmajo.20140040
|View full text |Cite
|
Sign up to set email alerts
|

Chronic obstructive pulmonary disease in primary care: an epidemiologic cohort study from the Canadian Primary Care Sentinel Surveillance Network

Abstract: CMAJ OPEN, 3(1) E15Research CMAJ OPEN C hronic obstructive pulmonary disease (COPD) is a substantial source of morbidity and mortality in Canada and globally. Estimates place the worldwide prevalence at 9%-10% from physiologic-based studies and 3%-8% from studies based on physician-or patient-reported diagnosis or symptoms.1,2 Globally, COPD is rated as the fifth leading cause of death, and ninth in contributions to loss of disability-adjusted life years.3,4 A recent systematic review of COPD epidemiology worl… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
15
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 27 publications
(20 citation statements)
references
References 25 publications
4
15
0
Order By: Relevance
“…Consistent with current literature, the use of SABD accounted for a significant proportion of medications used in our cohort of new medication users 1,17,24. This is expected considering the reasonable relative effectiveness of these classes of medications and their place as first-line therapies in previous and current COPD practice guidelines 22,23.…”
Section: Discussionsupporting
confidence: 86%
See 1 more Smart Citation
“…Consistent with current literature, the use of SABD accounted for a significant proportion of medications used in our cohort of new medication users 1,17,24. This is expected considering the reasonable relative effectiveness of these classes of medications and their place as first-line therapies in previous and current COPD practice guidelines 22,23.…”
Section: Discussionsupporting
confidence: 86%
“…The presence of multiple comorbidities is common among COPD patients, with the vast majority of patients using multiple classes of chronic non-COPD medications 1–3. In addition to significant effects on morbidity, COPD is the third leading cause of death in the world 4.…”
Section: Introductionmentioning
confidence: 99%
“…This study's COPD prevalence of 4.1% was similar to the 3.4% found by a Canadian study 22 but higher than 1.4% in a study from England. 23 Within the group of people with COPD, 86.0% had ≥1 comorbidities, slightly higher than the prevalence range of 76-82% found in three recent studies.…”
Section: Comparison With Existing Literaturesupporting
confidence: 68%
“…23 Within the group of people with COPD, 86.0% had ≥1 comorbidities, slightly higher than the prevalence range of 76-82% found in three recent studies. 5,22,24 The types of comorbidities included in different studies varied significantly, which is likely to account, at least in part, for these differences.…”
Section: Comparison With Existing Literaturementioning
confidence: 99%
“…At that time, the network included data from 444 sentinel physicians and nurse practitioners providing data on more than 440 000 patients from their practices in 7 provinces across Canada. Data from this period have been used consistently in a series of studies describing the prevalence and management of the 8 CPCSSN "index conditions" in primary care, [12][13][14][15][16] of which this study is the latest.…”
Section: Data Source and Study Populationmentioning
confidence: 99%